Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1762 Views
eMediNexus 25 February 2018
Sustained high serum TSH level during active surveillance is associated with progression of papillary thyroid microcarcinoma, says a study published in the February 2018 issue of the Journal of Clinical Endocrinology & Metabolism. Maintaining a low-normal TSH range with levothyroxine treatment during active surveillance may be considered, the study suggests.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}